Quotables
"The radio craze will die out in time."
Thomas Edison ; 1922
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7288542 | Non-nucleoside reverse transcriptase inhibitors The present invention relates to a compounds according to formula I, methods for treating diseases mediated by human immunodeficieny virus by administration of a compound according to formula I and pharmaceutical compositions for treating diseases mediated by human ... | 10/30/2007 |
| 7138133 | Orally administered liquid compositions The present invention is an orally administered liquid pharmaceutical composition that demonstrates excellent physical stability while delivering concentrated levels of the pharmaceutical active(s). Specifically, these compositions for extended periods do not allow ... | 11/21/2006 |
| 7094429 | Process for preparing tannate liquid and semi-solid dosage forms An active ingredient from the group of an antihistamine, a decongestant, an antitussive or anticholinergic is dissolved in a suitable solvent and added to a dispersion of tannic acid in water to form the tannate salt complex of the active ingredient. The active ingr... | 08/22/2006 |
| 6939856 | Method for preparing dexchlor tannate The invention pertains to a method for preparing dexchlorpheniramine (“dexchlor”) tannate by reacting dexchlorpheniramine free base at a temperature of about 75 to about 150° C. with tannic acid neat or as an aqueous slurry containing up to about 20 wt. % water... | 09/06/2005 |
| 6869618 | Process for preparing tannate liquid and semi-solid dosage forms An active ingredient from the group of an antihistamine, a decongestant, an antitussive or anticholinergic is dissolved in a suitable solvent and added to a dispersion of tannic acid in water to form the tannate salt complex of the active ingredient. The active ingr... | 03/22/2005 |
| 6790849 | Methods and compositions using optically pure (-) cetirizine in combination with leukotriene inhibitors or decongestants Methods and pharmaceutical compositions employing (+) cetirizine, (−) cetirizine, or racemic cetirizine, or a pharmaceutically acceptable salt thereof, and a leukotriene inhibitor, or a pharmaceutically acceptable salt thereof, or decongestant for the treatment, m... | 09/14/2004 |
| 6670370 | Dextromethorphan tannate The invention pertains to a composition comprising dextromethorphan tannate and to a method for preparing dextromethorphan tannate by reacting dextromethorphan at a temperature of about 80 to about 180° C. with tannic acid either neat or as an aqueous sl... | 12/30/2003 |
| 6566396 | Antitussive/antihistaminic compositions Tannate compositions consisting essentially of carbetapentane tannate and chlorpheniramine tannate which are effective when administered orally for the symptomatic relief of coryza associated with the common cold, sinusitis, allergic rhinitis, unproductiv... | 05/20/2003 |
| 6384038 | Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants Methods and pharmaceutical compositions employing (+) cetirizine, (-) cetirizine, or racemic cetirizine, or a pharmaceutically acceptable salt thereof, and a leukotriene inhibitor, or a pharmaceutically acceptable salt thereof, or decongestant for the tre... | 05/07/2002 |
| 6362197 | Compositions and method for treatment of cough Pharmaceutical compositions possessing anti-tussive activity, and a method of administering the same to warm-blooded animals, including humans.... | 03/26/2002 |
| 6335030 | Transdermally administered dextromethorphan as antitussive agent The present invention is drawn to a device for the transdermal administration of dextromethorphan, (+)-3-methoxy-17-methyl-9a,13a,14a-morphanin, and salts, prodrugs and metabolites thereof, together with a pharmaceutically acceptable carrier, to a hu... | 01/01/2002 |
| 6211152 | Formulations for peptide release A pharmaceutical and/or veterinary formulation comprising deslorelin and an excipient, the formulation being characterised in that, in vitro, it releases deslorelin into phosphate buffered saline, as hereinbefore described, at 37° C. at a rate of about 2... | 04/03/2001 |
| 6194460 | Composition for treating cough induced by angiotensin converting enzyme inhibitors The claims define a method which is based on the use of baclofen to suppress the cough of a patient who is afflicted with a cough that is induced by the administration of an ACE inhibitor. The usual dose of baclofen is from 10 to 30 mg daily. A pharmaceut... | 02/27/2001 |
| 6121290 | Use of GABA uptake inhibitors as anti-tussive agents Invention is a method of treating cough in a mammal, including a human, which comprises administering to such mammal an effective amount of an inhibitor of GABA uptake.... | 09/19/2000 |
| 6001392 | Antitussive drugs delivered by ion exchange resins The present invention relates generally to a mixture of coated and non-coated sulfonic acid cation exchange resins (Amberlite IR69) cross-linked with about 8% divinyl benzene onto which dextromethorphan has been loaded. About 30% of the drug/resin complex... | 12/14/1999 |
| 5932589 | Antitussive composition containing dextromethorphan and benzydamine Oral antitussive pharmaceutical composition which allows a significant contact of its components with mucous membranes of the buccal cavity and comprises a centrally acting antitussive or a pharmaceutically acceptable salt thereof and benzydamine or a pha... | 08/03/1999 |
| 5760085 | Topical aromatic releasing compositions The present invention relates to topical aromatic releasing compositions containing one or more volatile aromatic compounds selected from the group consisting of 3-1-menthoxy propane-1,2-diol, N-substituted-p-menthane-3-carboxamides and acyclic carboxamid... | 06/02/1998 |
| 5730997 | Tastemasked liquid pharmaceutical delivery system A substantially tasteless liquid phramaceutical delivery system containing an active material and a high osmolarity aqueous system comprising (i) water; (ii) about 20% to about 45% by weight sugar derivative; (iii) about 10% to about 15% by weight hydroge... | 03/24/1998 |
| 5622992 | Topical aromatic releasing compositions The present invention relates to topical aromatic releasing compositions containing one or more volatile aromatic compounds selected from the group consisting of 3-1-menthoxy propane-1,2-diol, N-substituted-p-menthane-3-carboxamides and acyclic carboxamid... | 04/22/1997 |
| 5534552 | Clear non-alcoholic sinus and allergy medication A clear, hypoallergenic sinus and allergy medication is orally administered in an aqueous, liquid dosage form. The formulation provides effective sinus and allergy relief without alcohol or dyes which adversely affect many allergy sufferers. Said relief i... | 07/09/1996 |
| 5514665 | Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans Methods for reducing the risk of or preventing infections by bacterial pathogens in vivo. In particular, a method for reducing the risk of P. aeruginosa infection in vivo in compromised hosts such as cystic fibrosis patients. The methods involve the use o... | 05/07/1996 |
| 5422357 | Method of using oxatomide as antitussive agent Oxatomide reduces the number of cough attacks and also prolongs the time between each attack. The effect is dose-related.... | 06/06/1995 |
| 5409907 | Aqueous pharmaceutical suspension for pharmaceutical actives The present invention relates to an aqueous pharmaceutical suspension composition comprising: from about 0.2% to 20% of a substantially water soluble pharmaceutical active, e.g. acetaminophen; a suspension stabilizing effective amount of xanthan gum and m... | 04/25/1995 |
| 5352703 | Antitussive and mucus regulating agent, a process for the preparation thereof and pharmaceutical compositions containing it 2-benzoylamino-3,5-dibromo-N-(4-hydroxycyclohexyl)benzylamine of formula (I), and pharmaceutically acceptable acid addition salts have antitussive and mucus regulating activities. ##STR1##... | 10/04/1994 |
| 5272137 | Aqueous pharmaceutical suspension for pharmaceutical actives The present invention relates to an aqueous pharmaceutical suspension composition comprising: from about 0.2% to 20% of a substantially water soluble pharmaceutical active, e.g. acetaminophen; a suspension stabilizing effective amount of xanthan gum and m... | 12/21/1993 |
| 5223541 | Tramadol N-oxide material, enantiomers and compositions thereof, and their use This invention relates to a tramadol N-oxide material, enantiomers and compositions thereof and their use. The tramadol N-oxide material and compositions thereof are pharmacologically useful in treating pain, diarrhea and tussive conditions. The tramadol ... | 06/29/1993 |
| 5100898 | Antitussive liquid compositions containing dyclonine Novel antitussive and anesthetic liquid compositions of matter for oral use comprising an effective oral antitussive drug and dyclonine; and method of using same.... | 03/31/1992 |
| 5013554 | Oral pharmaceutical compositions containing dextrophan salts Dextrorphan salts with polycarboxylic organic acids are effectively absorbed by the oral route and can conveniently be formulated in pharmaceutical compositions suitable to the oral administration.... | 05/07/1991 |
| 5006560 | Use of GABA-B selective agonists as anti-tussive agents A method for treating cough in a mammal comprising administering to said mammal an anti-tussive effective amount of a GABA-B selective agonist such as ##STR1## is described.... | 04/09/1991 |
| 4971798 | Hard confections containing hydrogenated isomaltulose and medicinally active ingredient Disclosed is a hard confection containing Palatinit (hydrogenated isomaltulose) and a medicinally active ingredient. Such a formulation has been found to dissolve more slowly than similar formulations based on sugar rendering them suitable for dispensing ... | 11/20/1990 |
| 4892877 | Antitussive liquid compositions containing phenol Novel antitussive and anesthesic liquid compositions of matter for oral use comprising an effective oral antitussive drug and phenol, and method of using same.... | 01/09/1990 |
| 4798898 | Antitussive and mucus regulating 2-substituted thiazolidines 2-Substituted thiazolidines compounds having formula I ##STR1## wherein X is a CH2, O or S, R is hydroxy or an acyloxy, alkyloxy, alkenyloxy or alkinyloxy group, R1 is hydrogen or a group of formula ##STR2## R2 i... | 01/17/1989 |
| 4788055 | Resinate sustained release dextromethorphan composition A pharmaceutical preparation for controlled, sustained release of dextromethorphan comprising a polystyrene sulfonate resin which has been cross-linked with about 3% to about 10% divinyl benzene, having an average particle size of at least 48 μm and less... | 11/29/1988 |
| 4775694 | Antitussive composition The invention relates to an oral pharmaceutical composition containing benzonatate. More particularly it concerns a composition of this character having improved taste and demulcency characteristics as well as one which minimizes the local anaesthesia to ... | 10/04/1988 |
| 4767612 | Triamcinolone acetonide for the treatment of allergic rhinitis Disclosed is a method for the treatment of allergic rhinitis that manifests itself as rhinorrhea, nasal itching, sneezing, congestion and postnasal drip. The method comprises the administration from a nasal aerosol dispenser an effective amount of microni... | 08/30/1988 |
| 4762719 | Powder filled cough product A cough drop is provided comprising a hard candy outer shell and a powdered centerfill containing a rapidly-dissolving powder such as dextrose monohydrate and an active ingredient such as menthol and eucalyptus which is preferably in the form of a liquid ... | 08/09/1988 |
| 4650663 | Magnesium trisilicate suitable for preparation of medicament adsorbates of antitussives A medicament adsorbate containing a magnesium trisilicate having a surface area of at least 400 m2 /g and having a flake-like structure with multiple interstitial spaces, and having adsorbed therein from about 1% to about 20% by weight of the a... | 03/17/1987 |
| 4461895 | Dibenzo(de,g)quinolines The present invention provides dibenzo(de,g)quinoline derivatives of the general formula: ##STR1## wherein R is an unsaturated aliphatic hydrocarbon radical containing up to 6 carbon atoms or a cycloalkylalkyl radical containing 4 to 6 carbon at... | 07/24/1984 |
| 4454140 | Nasal administration of dextromethorphan The invention relates to a novel method of administering dextromethorphan, a known anti-tussive agent used for the suppresion of coughs due to colds and allergies. The novel method utilizes dosage forms of dextromethorphan which are adapted for nasal admi... | 06/12/1984 |
| 4427681 | Thixotropic compositions easily convertible to pourable liquids Compositions employing titanium dioxide as an opacifying agent and which are thixotropic gels easily convertible to pourable liquids with moderate shaking are provided by employing Avicel.RTM. RC-591 as the suspending agent for the composition.... | 01/24/1984 |
